Definium Therapeutics stock hits 52-week high at 19.66 USD
#Definium Therapeutics #stock hits 52-week high #19.66 USD #market performance #stock price #financial news
📌 Key Takeaways
- Definium Therapeutics stock price reached a 52-week high.
- The shares closed at 19.66 USD.
- The stock is trading at a yearly peak.
- The company has achieved a significant milestone in its stock performance.
🏷️ Themes
Stock Market, Company Performance
📚 Related People & Topics
Definium Therapeutics
Psychedelic medicine biotech company
Definium Therapeutics, Inc., formerly known as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs.
Entity Intersection Graph
No entity connections available yet for this article.